Illumina Inc (NASDAQ:ILMN)., a leading player in the genomic sequencing industry, finds itself at a critical juncture as it navigates a shifting competitive landscape and global economic challenges.

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...

The manuscript addresses the 3D chromatin architecture in monocytes from patients with alcohol-associated hepatitis and its relationship to enhanced transcription of innate immune genes. While the ...

This study identifies 47,350 enhancers active in human neurons during differentiation and links some to genes involved in ...

Shares of gene-sequencing leader Illumina have fallen 15% from Friday. Rivals 10X Genomics and Pacific BioSciences of California lost 18% and 15%, respectively. We recently published a list of Jim ...

New Xbox Series X games will start arriving thick and fast once over the next few months, with new exclusives launching on Microsoft's most powerful consoles. There's certainly a lot to look ...

It's early in 2025 and already, there are a huge deal of upcoming Xbox Series X games on the way. February will see a slew of new games land on the platform and Game Pass, with Obsidian's own RPG ...

Ploidy values are indicated in the y-axis; in the x-axis the alternation of different chromosomes are plotted with different colors. CNAs in the CTC are indicated in red and blue.

Gerdau S/A Ord 0.00% R$34.96B ...